US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Latest News about Psilera

Recent news which mentions Psilera

Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
Tickers NEWS
Tags Onsero Therapeutics Aaron Koenig Psychedelics
From Benzinga
This Company's Psilocybin-Based Non Hallucinogenic Compound Heads Toward Clinical Studies
Tags Benzinga Psilera Psychedelics
From Benzinga
Another Win For Non-Hallucinogens: Meet Psilera's Candidates Poised For Clinical Stage Milestone
Tags Psilera Non/Hallucinogenic Psychedelic Compound Benzinga
From Benzinga
Iter Closes Last Funding Round Of Psychedelics Pool, Higher Capital Market Investment Than Expected
Tags Market News News Dustin Robinson
From Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
Tickers AWKNF BRAXF CYBN FORA
Tags California Cantor Fitzgerald FORA
From Benzinga
Can Psychedelics Reduce Alcohol Consumption? A New Study Looks Into It
Tags News Cannabis Market News
From Benzinga